I now have comprehensive information. Let me compile the full OPD management guide with prescriptions.
OPD Management of Vomiting - Complete Guide
1. Initial Assessment (History & Examination)
Key history points:
- Onset, duration, frequency, severity
- Character: projectile, bilious, blood-tinged (hematemesis)?
- Associated symptoms: fever, diarrhea, abdominal pain, headache, vertigo, jaundice
- Timing: morning (pregnancy, raised ICP, alcoholism), post-meal (gastroparesis, pyloric obstruction)
- Medications (opioids, NSAIDs, digoxin, chemotherapy, antibiotics)
- Recent travel, dietary history
- Last menstrual period (rule out pregnancy in women of childbearing age)
- Signs of dehydration: dry mucosa, reduced skin turgor, tachycardia, decreased urine output
Red flag signs requiring urgent referral/admission:
- Projectile vomiting (raised ICP)
- Hematemesis
- Severe dehydration (unable to keep fluids down)
- Signs of peritonitis
- Altered consciousness or neurological signs
- Suspected bowel obstruction
2. Common OPD Causes
| Category | Examples |
|---|
| GI infections | Gastroenteritis, food poisoning |
| Pregnancy | NVP (morning sickness), hyperemesis gravidarum |
| Vestibular | Motion sickness, vertigo (labyrinthitis, BPPV) |
| Drug-induced | NSAIDs, opioids, antibiotics, digoxin |
| Functional | Gastroparesis, functional dyspepsia |
| Metabolic | DKA, uremia, hypercalcemia, Addison's |
| CNS | Migraine, raised ICP |
| Post-operative | PONV |
3. Investigations (if needed)
- CBC, RBS, LFT, RFT, serum electrolytes (Na+, K+)
- Urine pregnancy test (women of childbearing age)
- Urinalysis (ketonuria suggests starvation/DKA)
- Urine routine + culture (if UTI suspected)
- USG abdomen (if hepatobiliary/obstruction suspected)
4. General Non-Pharmacological Management
- Rest and oral rehydration - small, frequent sips of fluids (ORS/coconut water/clear fluids)
- Dietary advice: bland, low-fat diet; avoid spicy/fatty foods; small frequent meals rather than large meals
- Avoid triggers (odors, motion, large meals, alcohol)
- Ginger - evidence supports ginger for morning sickness and motion sickness (effective vs. placebo for seasickness, morning sickness, and chemotherapy-induced N&V)
- Elevate head of bed if gastroesophageal reflux suspected
- Adequate hydration monitoring (ketonuria = starvation signal)
5. Pharmacological Management - Antiemetic Drug Classes
The vomiting center contains muscarinic M1, histamine H1, NK1, and serotonin 5-HT3 receptors. The chemoreceptor trigger zone (CTZ) is rich in dopamine D2 receptors and opioid receptors. Vestibular system has M2 and H1 receptors. Targeting the right receptor depends on the etiology.
(Katzung's Basic and Clinical Pharmacology, 16th Ed.)
6. Sample OPD Prescriptions by Etiology
A. Acute Gastroenteritis / Food Poisoning (Most Common OPD Cause)
Rx:
1. Tab. Metoclopramide 10 mg - 1 tab TDS x 3-5 days
(Before meals; avoid in children <1 yr; max 5 days due to extrapyramidal risk)
2. ORS sachet - 1 sachet in 200 mL water after every loose stool/vomiting episode
3. Tab. Ondansetron 4 mg - 1 tab TDS x 3-5 days
(If metoclopramide not tolerated or vomiting severe; also available as 4 mg ODT)
4. Tab. Pantoprazole 40 mg - 1 tab OD before breakfast x 5-7 days
(If associated dyspepsia/heartburn)
If dehydrated: IV/ORS hydration. Refer if unable to tolerate orally.
B. Pregnancy-Related Nausea & Vomiting (1st Trimester)
Rx:
1. Cap./Tab. Doxylamine 10 mg + Pyridoxine (Vit B6) 10 mg
- 2 tabs at bedtime; can add 1 tab in morning and 1 at mid-afternoon
(First-line; Category A in pregnancy)
2. Tab. Ondansetron 4 mg - 1 tab TDS x 5 days
(2nd line; avoid in 1st trimester if possible, but used when benefits outweigh risk)
3. Tab. Metoclopramide 10 mg - 1 tab TDS
(Safe in pregnancy as adjunct)
4. Tab. Pyridoxine (Vit B6) 25 mg - 1 tab TDS
5. Ginger capsules 250 mg QID (non-pharmacologic option)
Hyperemesis gravidarum (weight loss, ketonuria, electrolyte disturbance) - ADMIT for IV fluids, IV antiemetics, IV thiamine (to prevent Wernicke's encephalopathy).
C. Motion Sickness
Rx (30-60 minutes before travel):
1. Tab. Cinnarizine 25 mg - 1 tab 30 min before travel, then 1 tab every 8 hours
(H1 + calcium channel blocker; preferred for vertigo/motion sickness)
OR
2. Tab. Dimenhydrinate (Dramamine) 50 mg - 1 tab 30-60 min before travel; repeat every 4-6 hours
(H1 antihistamine + anticholinergic; causes sedation)
OR
3. Scopolamine transdermal patch 1.5 mg - Apply behind ear 4 hours before travel
(Best for prolonged motion sickness; anticholinergic effects common orally)
4. Tab. Meclizine 25 mg - 1 tab OD
(Less sedating H1 antagonist; vertigo due to labyrinth dysfunction)
D. Drug-Induced Vomiting (Opioid, Antibiotics, NSAIDs)
Rx:
1. Tab. Ondansetron 4 mg - 1 tab TDS (with each dose of offending drug)
2. Tab. Domperidone 10 mg - 1 tab TDS before meals
(Peripheral dopamine D2 antagonist; less CNS/extrapyramidal effects than metoclopramide;
Does NOT cross BBB well; preferred over metoclopramide for GI-origin emesis)
3. Consider dose reduction or substitution of the causative drug
E. Vomiting with Dyspepsia / Gastroparesis / Functional
Rx:
1. Tab. Domperidone 10 mg - 1 tab TDS 15-30 min before meals x 2-4 weeks
(Prokinetic; increases lower esophageal sphincter tone and gastric emptying)
2. Tab. Metoclopramide 10 mg - 1 tab TDS x 5 days
(Short-term only due to tardive dyskinesia risk with prolonged use)
3. Tab. Pantoprazole/Omeprazole 40/20 mg - 1 tab OD before breakfast x 4 weeks
(If associated GERD/dyspepsia)
4. Tab. Itopride 150 mg TDS (newer prokinetic with dual mechanism)
F. Vertigo-Associated Vomiting (Labyrinthitis / BPPV)
Rx:
1. Tab. Betahistine 8-16 mg - 1 tab TDS x 2-4 weeks
(Histamine agonist at H1; reduces endolymph pressure; useful in Meniere's)
2. Tab. Cinnarizine 25 mg - 1 tab TDS x 1-2 weeks
(Vestibular sedative; H1 + calcium blocker)
3. Tab. Prochlorperazine 5 mg - 1 tab TDS (or 3-12.5 mg buccal for acute attacks)
(Phenothiazine; dopamine antagonist; good for vestibular vomiting)
4. Epley's maneuver (for BPPV - refer physiotherapy)
G. Post-operative / Chemotherapy-Induced (for information)
- CINV acute: Ondansetron 8 mg IV/oral + Dexamethasone 8-12 mg + Aprepitant 125 mg (NK1 antagonist) 1 hr before chemo
- Delayed CINV: Aprepitant 80 mg OD x 2 days + Dexamethasone
- PONV prophylaxis: Ondansetron 4 mg IV + Dexamethasone 4-8 mg IV at end of procedure
7. Antiemetic Drug Summary Table
| Drug | Class | Mechanism | Dose (Adult) | Key Use |
|---|
| Ondansetron | 5-HT3 antagonist | Blocks 5-HT3 at CTZ + vagal afferents | 4-8 mg TDS | Chemo/post-op/acute vomiting |
| Metoclopramide | Substituted benzamide | D2 blockade + prokinetic | 10 mg TDS (max 5 days) | Gastroenteritis, functional |
| Domperidone | D2 antagonist (peripheral) | Peripheral D2 block; prokinetic | 10 mg TDS | Gastroparesis, dyspepsia |
| Promethazine | Phenothiazine/H1 | D2 + H1 blockade | 12.5-25 mg TDS | Versatile; motion sickness |
| Prochlorperazine | Phenothiazine | D2 + muscarinic blockade | 5-10 mg TDS | Vestibular vomiting |
| Cinnarizine | H1 + Ca-channel blocker | H1 block + vestibular sedation | 25 mg TDS | Motion sickness, vertigo |
| Doxylamine + B6 | H1 + vitamin | H1 antihistamine | 2 tabs hs | NVP (1st line) |
| Aprepitant | NK1 antagonist | NK1 receptor block | 125 mg day 1, 80 mg x 2 days | Chemo-induced (delayed) |
| Lorazepam | Benzodiazepine | CNS/anticipatory anxiety | 0.5-2 mg | Anticipatory CINV |
| Scopolamine | Anticholinergic | M1/M2 muscarinic block | 1.5 mg patch | Motion sickness |
8. Important Cautions
- Metoclopramide: Do NOT use >5 days (risk of tardive dyskinesia, extrapyramidal effects). Contraindicated in GI obstruction, perforation, phaeochromocytoma.
- Domperidone: Risk of QTc prolongation at high doses. Use lowest effective dose.
- Ondansetron: Avoid in congenital long QT syndrome. Headache, constipation are common side effects. Dose reduction required in hepatic impairment.
- Phenothiazines (promethazine, prochlorperazine): Extrapyramidal side effects, hypotension, sedation. Avoid in Parkinson's disease.
- Antihistamines (dimenhydrinate, meclizine): Sedation, dry mouth, urinary retention, cycloplegia - use cautiously in elderly, BPH, glaucoma.
- Aprepitant (NK1): CYP3A4 interactions - can affect warfarin (decreases INR), dexamethasone dosing needs reduction.
9. When to Refer/Admit
- Unable to maintain oral hydration
- Signs of severe dehydration (>10% weight loss, ketonuria)
- Hematemesis or "coffee ground" vomiting
- Vomiting >3 weeks (chronic - needs workup for malignancy, gastroparesis)
- Projectile vomiting + headache/papilledema (raised ICP - neurosurgical emergency)
- Suspected bowel obstruction
- Hyperemesis gravidarum with weight loss and electrolyte imbalance
Sources:
- Katzung's Basic and Clinical Pharmacology, 16th Edition - Antiemetic Agents chapter (pp. 1716-1719)
- Tintinalli's Emergency Medicine - Nausea and Vomiting management
- Lippincott Illustrated Reviews: Pharmacology - Antiemetic drugs